Drug Law Weekly

Columbia University, New York - HAART extends HIV+ women's survival, but doesn't improve mental health

Conor Medsystems, Inc. - Company initiates COSTAR II pivotal drug-eluting stent clinical trial in U.S.

Cutting Edge Information - Clinical trials run far beyond initial expectations

Cylene Pharmaceuticals - Oncology drug-discovery company raises $26.3M in series B financing

Cylex, Inc. - ImmuKnow receives clinical support in five independent studies

Dana Farber Cancer Institute - Endothelial growth factor receptor inhibitor studied, varied effects noted

Dana Farber Cancer Institute, Boston - Researchers suggest an effective immunoprophylaxis strategy in outbreak setting

Dana-Farber Cancer Inst. - Novel combination overcomes drug-resistant myeloma cells

Danish Cancer Society, Copenhagen - Developmental resistance to endocrine therapy studied in breast cancer cell line

DeveloGen, AG - Specialty pharma names new scientific advisory board, changes management team

DiaKine Therapeutics - IND application for Lisofylline aquired from Cell Therapeutics

Dr. Joseph L. DeStefano - Physician comments on U.S. National Institutes of Health panel stance on HRT

Duisburg Essen University, Essen - Niacin is a valuable therapy component in patients with dyslipidemia

Dutch Speaking Free University of Brussels - In vitro maturation plus natural cycle IVF has promise as low-cost alternative

Epigenomics AG - DNA methylation of PSAT1 linked to endocrine therapy response

Erasmus Medical Center - Studies describe new findings in diabetic nephropathy research

Favrille, Inc. - Patients being enrolled in Rituxan trial for follicular NHL

Genentech, Inc. - Phase III clinical data from Tarceva trial presented

Generex Biotechnology Corp. - Buccal drug-delivery company establishes presence in Europe & the Middle East

German Cancer Research Center - Triple approach is promising against cancer cells

Hawaii Biotech, Inc. - Biotech launches vaccine program to protect native Hawaiian birds from West Nile

Hollis-Eden Pharmaceuticals - New drug being developed for the treatment of acute radiation syndrome

Hospital for Special Surgery - Hospital for Special Surgery awarded patent for new shoulder prosthesis design

La Jolla Pharmaceutical Company - Pharmaceutical company provides update finances, trials on lupus renal drug

MD Anderson Cancer Center, Houston - Celecoxib can be safely used concurrently with thoracic radiotherapy

Mercy Catholic Medical Center, Darby - Simple barrier methods may prevent Crimean-Congo hemorrhagic transmission

Mylan Laboratories Inc. - FDA approvable letter received for Nebivolol

Onset Medical Corp. - Medical technology firm initiates use of ureteroscopy access device

R2 Technology, Inc. - Breast cancer CAD technology company introduces new product to line

Somanetics Corporation - Pre-market notification submitted to U.S. FDA to expand technology labeling

Spectrum Pharmaceuticals, Inc. - U.S. FDA authorizes clinical trial in drug for hormone dependent prostate cancer

StemCell Pharma, Inc. - Pharma company acquires rights to implant stem cells for Alzheimer disease

Teva Pharmaceutical Industries Ltd. - U.S. FDA grants approval of generic antibiotic Biaxin Tablets 250 mg and 500 mg

The American Fertility Association - Fertility organization comments on U.S. FDA donor eligibility guideline revision

TriCounty Hlth Department, Greenwood Village -  Escherichia coli O157:H7 outbreak associated with ground beef contamination

U.S. DeKalb County Board of Health, Decatur - Multifaceted surveillance plan decreases West Nile virus infection risk

U.S. Food and Drug Administration - Interleukin-4 cytotoxin may be a unique agent against Hodgkin lymphoma

United States Food and Drug Administration - Adverse events linked to breast pumps

Univ. of California, Los Angeles - UCLA awarded more than $6 million for biodefense and infectious disease research